Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006177 · ClinicalTrials.gov registry record
Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study
A clinical trial of Bipolar Disorder and Mood Disorders, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 1,303
- Enrollment target
- 1
- Study location
NCT00006177 is a study of Bipolar Disorder and Mood Disorders that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 1,303 participants, above the 325-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (301% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00006177, a study of Bipolar Disorder and Mood Disorders, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 1,303 participants
- Enrollment target
- 1
- Study location
Study Summary
This research protocol seeks to learn more about bipolar disorder in children and adolescents ages 6-17. Researchers will describe the moods and behaviors of children with bipolar disorder and use specialized testing and brain imaging to learn about specific brain changes associated with the disorder. This protocol studies children who have been diagnosed with bipolar disorder, and those who have a sibling or parent with bipolar disorder and are thus considered "at risk" for developing the disorder.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,303 participants |
| Start Date | 2000-08-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006177
The ClinicalTrials.gov registry entry for NCT00006177 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,303 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 325-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (301% higher). The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT00006177 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00006177 about?
NCT00006177 is a clinical study titled "Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study". This research protocol seeks to learn more about bipolar disorder in children and adolescents ages 6-17. Researchers will describe the moods and behaviors of children with bipolar disorder and use specialized testing and brain imaging to learn about specific brain changes associated with the disorde...
What is the current status of trial NCT00006177?
This trial is currently completed. The enrollment target is 1,303 participants. The study started on 2000-08-11.
What conditions does trial NCT00006177 study?
This clinical trial studies the following conditions: Bipolar Disorder, Mood Disorders, Attention Deficit Hyerpactivity Disorder.
Who is sponsoring clinical trial NCT00006177?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00006177 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.